Tumor-Targeting Probiotic Bacteria: A Breakthrough in Targeted Cancer Therapy

In this episode, we explore an innovative approach to cancer treatment using engineered probiotic bacteria, an emerging strategy that could transform how tumors are targeted and treated.

You’ll learn:

• What tumor-targeting probiotic bacteria are and how they work
•  How engineered microbes can locate tumors and produce cancer-fighting drugs on site
•  Why E. coli Nissle 1917 is being used as a safe and promising probiotic strain
•  How the drug romidepsin is delivered directly within the tumor microenvironment
•  Key findings from early mouse studies and what they reveal about tumor growth reduction
•  The potential benefits of this approach, including fewer side effects compared to chemotherapy
•  The major challenges scientists still face include safety, control, and human testing

While still in the early research stage, this breakthrough highlights the future of more precise, targeted cancer therapies. Learn how scientists are turning bacteria into powerful tools in the fight against cancer and what it could mean for patients in the years ahead.

Blog Link: Tumor-Targeting Probiotic Bacteria for Cancer Therapy

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.